GlassScriptPhysician profile
Dyanet Loreta Alvarez
NPI 1083241020
$1,300.50
in general payments reported to CMS, 2019-2025
20 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $83.22 · 2024: $48.07 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283 · Education: $17.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.60 |
| Education | $17.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.86 | 2024-2025 | |
| Ucb, INC. | $149.94 | 2023-2025 | Briviact, Nayzilam |
| Tg Therapeutics, INC. | $128.02 | 2025 | |
| Lilly USA, LLC | $87.11 | 2025 | Kisunla |
| Jazz Pharmaceuticals INC. | $80.93 | 2023-2025 | Epidiolex |
| Astrazeneca Pharmaceuticals LP | $77.47 | 2025 | Wainua |
| Merz Pharmaceuticals, LLC | $67.99 | 2025 | Xeomin, Inbrija, Ampyra |
| Eisai INC. | $57.76 | 2025 | |
| Argenx US, INC. | $55.12 | 2025 | Vyvgart Hytrulo |
| Neurocrine Biosciences, INC. | $54.06 | 2025 | |
| Janssen Biotech, INC. | $49.06 | 2025 | |
| Microtransponder, INC. | $42.66 | 2025 | |
| Sk Life Science, INC. | $26.83 | 2025 | |
| Acadia Pharmaceuticals INC | $26.62 | 2025 | Nuplazid |
| Axsome Therapeutics, INC. | $25.97 | 2025 | Symbravo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $21.51 | 2025 | Hizentra |
| Janssen Pharmaceuticals, INC | $17.90 | 2025 | |
| Hyperfine Operations, INC. | $16.93 | 2025 | Swoop |
| C2n Diagnostics, LLC | $16.86 | 2025 | Precivityad2 |
| Pfizer INC. | $13.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dyanet Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.